middle.news
Island Pharmaceuticals Advances Galidesivir with GMP Manufacturing for Marburg Study
9:03am on Thursday 4th of June, 2026 AEST
•
Pharmaceuticals
Read Story
Island Pharmaceuticals Advances Galidesivir with GMP Manufacturing for Marburg Study
9:03am on Thursday 4th of June, 2026 AEST
Key Points
GMP manufacturing underway with PI Health Sciences
Supports pivotal Marburg efficacy study under FDA Animal Rule
Existing Galidesivir stock to back dose optimisation trials
Establishes infrastructure for regulatory approval and biodefence procurement
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE